A vaccine just did something almost no medical intervention has ever done.
It drove the death count to zero.
Not "reduced." Not "significantly lower."
Zero.
In England, between 2020 and 2024, not a single woman aged 20–24 died of cervical cancer — if she'd been vaccinated against HPV as a schoolgirl.
The study just landed in The Lancet. And the numbers are the kind that stop you mid-scroll.
England started jabbing 12–13 year-old girls back in 2008.
Nearly two decades later, that quiet schoolyard programme is now the closest thing modern medicine has to a cheat code against a cancer that kills hundreds of thousands of women globally.
India carries one of the heaviest cervical cancer burdens on the planet.
That's one Indian woman dying roughly every 7 minutes.
On February 28, PM Modi launched India's nationwide HPV vaccination drive. The target: 1.15 crore girls aged 9–14.
The scoreboard so far:
For most of human history, cancer was something you fought after it found you.
Surgery. Chemo. Hope.
HPV flipped that script.
A few shots in early adolescence — and an entire generation of women may simply never get the disease their grandmothers died from.
The Lancet authors said it plainly: eliminating cervical cancer as a public health problem is achievable.
Not a dream. Not a slogan.
Achievable.
England just gave the world a working blueprint.
India is now running the largest test of that blueprint in human history.
If coverage holds — and if screening and treatment catch up — the next generation of Indian women could grow up in a country where cervical cancer is something they only read about in old textbooks.
That's not medicine.
That's history being rewritten in real time.
That's all for now!
